Video Experimental Relacionado

Updated: Jul 11, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Efecto de un inhibidor de RT no nucleósido enlazado en la dinámica de la transcriptasa inversa del tipo silvestre y

Zhigang Zhou¹, Marcela Madrid, Jeffrey D Evanseck

¹Department of Chemistry and Biochemistry and Center for Computational Sciences, Duquesne University, Pittsburgh, Pennsylvania 15282, USA.

Journal of the American Chemical Society

|December 8, 2005

Resumen

Los inhibidores no nucleósidos de la transcriptasa inversa (INRTIs) son cruciales para el tratamiento del SIDA. Este estudio revela cómo las mutaciones en la transcriptasa inversa (RT) del VIH-1 afectan la unión a NNRTI y la resistencia a los fármacos, ofreciendo ideas para desarrollar fármacos más efectivos.

Área de la Ciencia:

La bioquímica es la bioquímica.
Biología Molecular Biología Molecular
Descubrimiento de Drogas Descubrimiento de Drogas

Sus antecedentes:

La transcriptasa inversa (RT) del VIH-1 es un objetivo clave para la terapéutica del SIDA.
Los inhibidores de la RT no nucleosídicos (INRTN) interrumpen la función de la RT al alterar su dinámica.
La resistencia a los medicamentos a menudo surge de mutaciones en la enzima RT.

Objetivo del estudio:

Investigar el impacto de las mutaciones comunes de resistencia a la nevirapina (V106A, Y181C, Y188C) en la dinámica de la RT del VIH-1 y la unión de NNRTI.
Para dilucidar los mecanismos moleculares subyacentes a la resistencia a los NNRTI.

Principales métodos:

Las simulaciones de dinámica molecular (DM)
Análisis de los componentes principales (PCA)
Cálculos vinculantes de energía libre utilizando MM-PBSA.

Principales resultados:

Los NNRTI restringen el movimiento general de los aminoácidos RT del VIH-1.
Las mutaciones en el bolsillo de unión NNRTI restauran parcialmente la flexibilidad de RT.
La nevirapina exhibe una afinidad de unión más fuerte a la RT de tipo salvaje en comparación con las formas mutantes, atribuida a la reducción de las interacciones de van der Waals en los mutantes.

Conclusiones:

Las mutaciones de resistencia a los fármacos en el VIH-1 RT reducen la afinidad de unión de la nevirapina.
El diseño efectivo de NNRTI requiere inhibidores que ocupen eficientemente el bolsillo de unión y maximicen las interacciones con los aminoácidos circundantes.

Más Videos Relacionados

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Videos de Conceptos Relacionados

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Inhibitors Of Virion Release

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Inhibitors of Virion Maturation and Assembly

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...